+ 0.00
+ 0%
+ 0.00
+ 0%
+ 0.00
+ 0%
+ 0.00
+ 0%
+ 0.00
+ 0%

13F Season: A Look At Cliff Asness' AQR Capital's Diversified Portfolio

May 15, 2015 3:46 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Cliff Asness’ AQR Capital Management is also amongst the investment firms that were required to file a Form 13F -disclosing its long equity positions as of March 31- with the SEC.

According to the document, after acquiring 199 new stocks, boosting its stakes in another 928, trimming its exposure to 931 holdings, and selling out of 554, the fund declared having an equity portfolio worth approximately $43.75 billion.


Increased Exposure

Apple Inc. (NASDAQ: AAPL) occupied the first spot in Asness’ list. Following an 8 percent increase in its stake, AQR Capital held, as of March 31, 6,893,095 shares of Common Stock, worth about $857.7 million – which account for almost 2 percent of its equity portfolio’s total value.

Related Link: Barry Rosenstein, Jana Partners' Latest Moves Include Qualcomm, United Rentals And Yum Brands

Staples, Inc. (NASDAQ: SPLS) also felt the fund’s bullishness. Between January and March, inclusive, AQR acquired 7,186,086 shares of the company, taking its holdings to 7,265,302 shares of Common Stock, with a market value of $118,316,000.

AQR Capital also seems quite optimistic regarding Office Depot Inc (NASDAQ: ODP) and Target Corporation (NYSE: TGT), of which it bought 471,800 shares and 353,815 shares, respectively, over the quarter. The fund now owns 482,100 shares of Office Depot’s Common Stock, worth about $4.4 million, and 379,269 shares of Target’s Common Stock, valued at roughly $31.1million.

New Positions

Qorvo Inc (NASDAQ: QRVO) was Asness’ largest new acquisition. Over the quarter, the 13F says, the fund acquired 860,877 shares of Common Stock, worth $68,612,000 by the time of the filing.

Closed Out Stakes

The two largest long equity positions that were sold out during the quarter corresponded to Allergan, Inc. (NYSE: AGN) and Covidien plc (NYSE: COV), two healthcare companies that were sold in the first quarter.

Related Link: 13F Season: Tiger Cub Manish Chopra Seems Fond Of Consumer Discretionary Stocks

AQR had 824,609 shares of Allergan (worth $175 million) and 1,712,020 shares of Covidien (worth almost the same) by December 31, 2014. However, the fund sold its stakes when the company’s were acquired.

Allergan was acquired by Actavis in mid-March, and Covidien, by Medtronic, in late-January.

Related Articles

The SPY, QQQ And DIA All Plunged Today. Here's Why.

U.S. indices continued lower Tuesday amid weakness in tech stocks and potential profit-taking in financials and growth names.  read more

The QQQ, SPY And DIA All Fell Today. Here's Why.

U.S. indices traded lower Monday amid weakness in tech stocks and potential profit-taking in financials. read more

Here's Why Sunrun, Apple And Amazon Are Moving

Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders. Analysts arrive at stock ratings by researching public financial statements, communicating with executives and customers and following industry trends. Here are the latest analyst ratings and updates for Sunrun, Apple and Amazon. read more

What's Going On With Dogecoin, Bitcoin, IDEX Stock And UAL Stock?

Meme cryptocurrency Dogecoin (CRYPTO: DOGE) ran up nearly 80% in a 24-hour period and is trading above the psychologically important 10-cent mark. See also: How to Buy Dogecoin (DOGE) read more